Finally, interrogation of TCGA data sets revealed that the expression of the peroxisome marker ABCD3 and UGCG was also positively correlated with CD36 expression in other tumor types (Supplemental Figure 10D), suggesting that combined inhibition of peroxisomes and UGCG may have broader clinical utility. This evidence concerns the gene CD36 and neoplasm.